Has Sobia Ozair, MD received payments from drug or device companies?

Yes. Drug and device makers reported $378,165 in general payments to Sobia Ozair, MD across 348 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sobia Ozair, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sobia Ozair, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sobia Ozair, MD

Hematology & Oncology · Baton Rouge, LANPI 1629334347

Payments from drug & device makers

$378,165in general payments, 2019–2025

Across 348 payments — averaging $1086.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$287K
AstraZeneca$39K
Karyopharm Therapeutics Inc.$33K
Trillium Therapeutics USA, LLC$14K
Gilead$699
Daiichi Sankyo Inc.$668
plus $4K from 44 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	46	$287,206
AstraZeneca	31	$39,093
Karyopharm Therapeutics Inc.	2	$32,519
Trillium Therapeutics USA, LLC	1	$14,000
Gilead(2 entities)	35	$699
Daiichi Sankyo Inc.	33	$668
Pfizer	30	$565
Novartis	29	$512
Bristol Myers Squibb	24	$385
GSK	16	$309
Eisai Inc.	16	$306
AbbVie	9	$188
Pharmacyclics LLC, An Abbvie Company	4	$139
Fresenius Kabi USA, LLC	2	$124
Beigene USA, Inc.	6	$115
Intuitive Surgical	1	$111
Tersera Therapeutics LLC	3	$88
Sanofi	5	$88
Regeneron Healthcare Solutions, Inc.	4	$87
Sirtex Medical Inc	3	$84
Lilly USA, LLC	4	$72
Blueprint Medicines Corporation	4	$69
E.r. Squibb & Sons, L.L.C.	3	$51
Genentech USA, Inc.	3	$48
Incyte Corporation	2	$47
Springworks Therapeutics, Inc.	2	$41
Pharmaessentia USA Corporation	1	$37
CTI Biopharma Corp.	2	$35
Stemline Therapeutics Inc.	2	$35
Novocure Inc.	2	$35
Mirati Therapeutics, Inc.	2	$32
Amgen	2	$32
Seagen Inc.	2	$32
Progenics Pharmaceuticals, Inc.	1	$30
Sandoz	1	$26
Astellas Pharma US Inc	1	$25
Recordati_rare_diseases_inc.	1	$19
Macrogenics, Inc.	1	$19
Taiho Oncology, Inc.	1	$19
Tempus AI, Inc	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	1	$18
Bayer	1	$18
EMD Serono, Inc.	1	$17
Veracyte, Inc.	1	$17
Alnylam Pharmaceuticals Inc.	1	$16
Tesaro, Inc.	1	$16
Tactile Systems Technology Inc	1	$15
Pharmacosmos Therapeutics Inc.	1	$14
AVEO Pharmaceuticals, Inc.	1	$14
Array Biopharma Inc	1	$13

How this compares

$378,165 in reported general payments places this provider in the 85th percentile of 183 hematology & oncology providers in Louisiana.

See all hematology & oncology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$56,292

Medicare patients

141

Services billed

697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Baton Rouge

Hana SafahBaton Rouge$3.8M
Nakhle SabaBaton Rouge$2.4M
Victor LinBaton Rouge$2.3M
Marshall StaggBaton Rouge$1.6M
William VarnadoBaton Rouge$648K
Andrew DalovisioBaton Rouge$389K
Sanjay JunejaBaton Rouge$346K
Derrick SpellBaton Rouge$128K
Christopher McCanlessBaton Rouge$80K
Harry Sequeira GrossBaton Rouge$58K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →